Titel

Test and Treat COVID 65plus+

Kurzzusammenfassung

Patients over equal or older than 65 yearswill be treated with a hydroxychloroquine versus placebo reduced loading dose of 600mg on the first day followed with 400mg/day divided in 2x200mg for 6 more days resulting in a total duration of therapy of 7 days. Measurement of Hydroxychloroquine-levels will be performed on day 7, . A follow-up by video or telephone conference will be performed to observe drug intake and collect adverse events during treatment phase on a daily base on working days and once during the weekend (i.e. 6 out of 7 days). After treatment phase follow-up by telephone calls will be done on day 10, 30, 60 (+/- 2 days).

Zentren/Kontakt:

Universitätsklinikum Tübingen: Dr. Michael Bitzer, Email: michael.bitzer@med.uni-tuebingen.de

Universitätsklinikum Ulm: Dr. Thomas Seufferlein, Tel. 0731 50044501, Email: thomas.seufferlein@uniklinik-ulm.de

Details

 

Stand: 05.05.2020, Quelle: www.clinicaltrials.gov

Menü